Alerts
High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
PROTEUS suggests perioperative apalutamide plus ADT can improve outcomes before and after prostatectomy, raising a practical question: which high-risk patients should be intensified early?
Eye Health Moves From Charity Case to Investment Case
AI in Cardiology Moves From Promise to Policy Pressure
Europe’s Safe Hearts Plan Makes Prevention a Political Test
England’s Tirzepatide Rollout Shows Approval Is Not Access
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Huntington Gene Therapy Hits the Evidence Wall
Rare Disease Policy Moves Into the Individualised Therapy Era
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.